{"id":8879,"date":"2025-02-13T20:21:08","date_gmt":"2025-02-13T20:21:08","guid":{"rendered":"https:\/\/afcra-smo.org\/?p=8879"},"modified":"2026-06-04T15:07:19","modified_gmt":"2026-06-04T15:07:19","slug":"paludisme-recherche-clinique-afrique-innovations-2","status":"publish","type":"post","link":"https:\/\/afcra-smo.org\/en\/paludisme-recherche-clinique-afrique-innovations-2\/","title":{"rendered":"Innovation dans la Lutte contre le Paludisme : Un Nouveau Vaccin au Cameroun"},"content":{"rendered":"<figure class=\"wp-block-post-featured-image\"><img loading=\"lazy\" decoding=\"async\" width=\"390\" height=\"270\" src=\"https:\/\/afcra-smo.org\/wp-content\/uploads\/2026\/05\/Vaccination-Palu.png\" class=\"attachment-post-thumbnail size-post-thumbnail wp-post-image\" alt=\"\" style=\"object-fit:cover;\" srcset=\"https:\/\/afcra-smo.org\/wp-content\/uploads\/2026\/05\/Vaccination-Palu.png 390w, https:\/\/afcra-smo.org\/wp-content\/uploads\/2026\/05\/Vaccination-Palu-300x208.png 300w\" sizes=\"auto, (max-width: 390px) 100vw, 390px\" \/><\/figure>\n\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Avec environ 249 millions de cas de paludisme et 622 000 d\u00e9c\u00e8s dans le monde en 2022 dont la majorit\u00e9 des victimes sont des enfants de moins de cinq ans principalement en Afrique subsaharienne, l&rsquo;urgence de contrer cette maladie est palpable. Le Cameroun se positionne \u00e0 l&rsquo;avant-garde de la sant\u00e9 publique avec le d\u00e9ploiement d&rsquo;un nouveau vaccin contre le paludisme depuis le 22 janvier 2024.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">La r\u00e9cente introduction du <strong>vaccin RTS,S\/AS01<\/strong>, connu sous le nom de Mosquirix, au Cameroun marque une avanc\u00e9e majeure. Ce vaccin, d\u00e9velopp\u00e9 par GSK, a \u00e9t\u00e9 le premier \u00e0 recevoir l&rsquo;approbation de l&rsquo;OMS pour la lutte contre le paludisme, apr\u00e8s avoir d\u00e9montr\u00e9 une efficacit\u00e9 de protection mod\u00e9r\u00e9e contre le paludisme symptomatique dans les essais cliniques.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">L&rsquo;OMS a \u00e9galement donn\u00e9 son feu vert \u00e0 un autre <strong>vaccin, le R21\/Matrix-M<\/strong> en d\u00e9cembre 2023, qui a affich\u00e9 une efficacit\u00e9 impressionnante de 75% contre le paludisme symptomatique dans les zones o\u00f9 la transmission est fortement saisonni\u00e8re.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Le lancement du Mosquirix au Cameroun repr\u00e9sente un \u00e9v\u00e9nement historique dans la lutte mondiale contre le paludisme. Ce vaccin a montr\u00e9 qu&rsquo;il pouvait r\u00e9duire la mortalit\u00e9 toutes causes confondues de 13% chez les enfants qui le re\u00e7oivent.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Au moment o\u00f9 les moustiques sont devenus r\u00e9sistants aux insecticides et le parasite responsable du paludisme r\u00e9sistant aux m\u00e9dicaments antipaludiques, le d\u00e9ploiement du Mosquirix au Cameroun repr\u00e9sente un nouvel espoir. Avec l&rsquo;adoption continue de ces vaccins dans d&rsquo;autres pays africains, l&rsquo;avenir de la pr\u00e9vention du paludisme semble prometteur.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><em>Issatou Bella Diallo<\/em><\/p>","protected":false},"excerpt":{"rendered":"<p>Avec environ 249 millions de cas de paludisme et 622 000 d\u00e9c\u00e8s dans le monde en 2022 dont la majorit\u00e9 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":9275,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1],"tags":[62,48,49,59,61,58,60],"class_list":["post-8879","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-recherche-clinique","tag-cameroun","tag-essais-cliniques","tag-innovation","tag-medicaments","tag-paludisme","tag-sante-publique","tag-vaccins"],"acf":[],"uagb_featured_image_src":{"full":["https:\/\/afcra-smo.org\/wp-content\/uploads\/2026\/05\/Vaccination-Palu.png",390,270,false],"thumbnail":["https:\/\/afcra-smo.org\/wp-content\/uploads\/2026\/05\/Vaccination-Palu-150x150.png",150,150,true],"medium":["https:\/\/afcra-smo.org\/wp-content\/uploads\/2026\/05\/Vaccination-Palu-300x208.png",300,208,true],"medium_large":["https:\/\/afcra-smo.org\/wp-content\/uploads\/2026\/05\/Vaccination-Palu.png",390,270,false],"large":["https:\/\/afcra-smo.org\/wp-content\/uploads\/2026\/05\/Vaccination-Palu.png",390,270,false],"1536x1536":["https:\/\/afcra-smo.org\/wp-content\/uploads\/2026\/05\/Vaccination-Palu.png",390,270,false],"2048x2048":["https:\/\/afcra-smo.org\/wp-content\/uploads\/2026\/05\/Vaccination-Palu.png",390,270,false],"trp-custom-language-flag":["https:\/\/afcra-smo.org\/wp-content\/uploads\/2026\/05\/Vaccination-Palu.png",18,12,false]},"uagb_author_info":{"display_name":"afcra_admin","author_link":"https:\/\/afcra-smo.org\/en\/author\/afcra_admin\/"},"uagb_comment_info":0,"uagb_excerpt":"Avec environ 249 millions de cas de paludisme et 622 000 d\u00e9c\u00e8s dans le monde en 2022 dont la majorit\u00e9 [&hellip;]","_links":{"self":[{"href":"https:\/\/afcra-smo.org\/en\/wp-json\/wp\/v2\/posts\/8879","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/afcra-smo.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/afcra-smo.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/afcra-smo.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/afcra-smo.org\/en\/wp-json\/wp\/v2\/comments?post=8879"}],"version-history":[{"count":4,"href":"https:\/\/afcra-smo.org\/en\/wp-json\/wp\/v2\/posts\/8879\/revisions"}],"predecessor-version":[{"id":9444,"href":"https:\/\/afcra-smo.org\/en\/wp-json\/wp\/v2\/posts\/8879\/revisions\/9444"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/afcra-smo.org\/en\/wp-json\/wp\/v2\/media\/9275"}],"wp:attachment":[{"href":"https:\/\/afcra-smo.org\/en\/wp-json\/wp\/v2\/media?parent=8879"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/afcra-smo.org\/en\/wp-json\/wp\/v2\/categories?post=8879"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/afcra-smo.org\/en\/wp-json\/wp\/v2\/tags?post=8879"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}